The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EORTC CLTF 2021 | Positioning chlormethine gel for the treatment of mycosis fungoides
Marios Koumourtzis, MD, University of Athens Medical School, Andreas Syggros Hospital, Athens, Greece, discusses the use of chlormethine gel in the treatment of mycosis fungoides, a form of cutaneous T-cell lymphoma. Dr Koumourtzis describes how chlormethine gel is used in the first-line setting, as a maintenance therapy, or in combination with systemic agents in later-stage settings. This interview took place at the EORTC Cutaneous Lymphoma Group 20-21 meeting in Marseille.
